January 26, 2023

Johnson & Johnson deserves more credit for another healthy quarter and strong guidance



The new year has been tough on pharmaceutical stocks, including JNJ. But it should not be read as an indictment on the company's operations.



Source link

Read Previous

Microsoft announces $52.7 billion in Q2 revenue amid plans to layoff 10,000 workers | Engadget

Read Next

Twitter makes it easier to avoid the annoying ‘For You’ tab | Engadget

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

%d bloggers like this: